Your browser doesn't support javascript.
loading
Remarkable response to a novel ATR inhibitor in a patient with poorly differentiated neuroendocrine carcinoma.
Saito, Yoshihito David; Li, Zaibo; Lustberg, Maryam; Grenade, Cassandra; Wesolowski, Robert.
Affiliation
  • Saito YD; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Li Z; Department of Pathology, The Ohio State University Comprehensive Cancer Center, USA.
  • Lustberg M; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Grenade C; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Wesolowski R; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Electronic address: Robert.Wesolowski@osumc.edu.
Cancer Treat Res Commun ; 16: 9-12, 2018.
Article in En | MEDLINE | ID: mdl-31299005
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Treat Res Commun Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Treat Res Commun Year: 2018 Document type: Article Affiliation country: Country of publication: